2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Woolly Monkey Sarcoma Virus
Woolly Monkey Sarcoma Virus (WMSV) has been a subject of interest in cancer research due to its potential in understanding oncogenesis. Initially discovered in the 1960s, this retrovirus induces sarcomas in woolly monkeys, providing insights into the mechanisms of tumor development. By studying WMSV, researchers aim to unravel the intricate interplay between viral infection and cellular transformation, shedding light on key oncogenic pathways. Understanding how WMSV triggers sarcomagenesis may offer valuable clues for developing targeted therapies against related human cancers. Furthermore, exploring the molecular interactions between WMSV and host cells could unveil novel therapeutic targets and diagnostic markers, ultimately advancing cancer treatment strategies. Through continued investigation into WMSV, scientists aspire to translate their findings into innovative approaches for combating cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China